IntelliPharmaCeutics International Inc (IPCIF)
0.06
0.00 (0.00%)
USD |
OTCM |
May 22, 16:00
IntelliPharmaCeutics International Shareholders Equity (Quarterly): -12.88M for Aug. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
August 31, 2023 | -12.88M |
May 31, 2023 | -10.99M |
February 28, 2023 | -10.93M |
November 30, 2022 | -10.58M |
August 31, 2022 | -10.15M |
May 31, 2022 | -9.856M |
February 28, 2022 | -9.015M |
November 30, 2021 | -8.155M |
August 31, 2021 | -6.168M |
May 31, 2021 | -5.028M |
February 28, 2021 | -7.186M |
November 30, 2020 | -6.314M |
August 31, 2020 | -4.684M |
May 31, 2020 | -5.807M |
February 29, 2020 | -4.834M |
November 30, 2019 | -3.692M |
August 31, 2019 | -2.408M |
May 31, 2019 | -1.005M |
February 28, 2019 | 0.9066M |
November 30, 2018 | 4.102M |
August 31, 2018 | -4.959M |
May 31, 2018 | -1.030M |
February 28, 2018 | -2.724M |
November 30, 2017 | 0.3864M |
August 31, 2017 | -0.7928M |
Date | Value |
---|---|
May 31, 2017 | 0.8063M |
February 28, 2017 | 0.8713M |
November 30, 2016 | 1.116M |
August 31, 2016 | 1.753M |
May 31, 2016 | -1.969M |
February 29, 2016 | -1.054M |
November 30, 2015 | -0.1377M |
August 31, 2015 | 2.342M |
May 31, 2015 | 2.945M |
February 28, 2015 | 4.183M |
November 30, 2014 | 4.909M |
August 31, 2014 | 5.586M |
May 31, 2014 | 7.175M |
February 28, 2014 | 6.895M |
November 30, 2013 | -5.955M |
August 31, 2013 | -1.378M |
May 31, 2013 | -1.776M |
February 28, 2013 | -2.653M |
November 30, 2012 | -1.768M |
August 31, 2012 | -1.573M |
May 31, 2012 | -0.3461M |
February 29, 2012 | -3.534M |
November 30, 2011 | -3.093M |
August 31, 2011 | -2.413M |
May 31, 2011 | -3.935M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-12.88M
Minimum
Aug 2023
-1.005M
Maximum
May 2019
-7.204M
Average
-6.750M
Median
Shareholders Equity (Quarterly) Benchmarks
Acasti Pharma Inc | 64.68M |
Aurinia Pharmaceuticals Inc | 377.95M |
Edesa Biotech Inc | 4.324M |
Lexaria Bioscience Corp | 6.521M |
Xenon Pharmaceuticals Inc | 887.70M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.566M |
Total Liabilities (Quarterly) | 14.44M |
Debt to Equity Ratio | -0.1689 |
Current Ratio | 0.0597 |
Net Debt Paydown Yield | -1.59% |